Relmada Therapeutics (RLMD) Receivables - Other (2016 - 2023)
Relmada Therapeutics' (RLMD) quarterly Receivables - Other came in at -$512432.0 in Q1 2023, down 200.0% on a QoQ basis from $512432.0 in Q4 2022.
Relmada Therapeutics (RLMD) Receivables - Other (2016 - 2023) Analysis & Trends
Relmada Therapeutics (RLMD) has 7 years of Receivables - Other data on file, last reported at -$512432.0 in Q1 2023.
- On a quarterly basis, Receivables - Other changed N/A year-over-year to -$512432.0 in Q1 2023; TTM through Dec 2023 was -$512432.0, a 200.0% decrease from a year earlier, with the FY2023 full-year figure at -$512432.0, down 200.0% from the prior year.
- Receivables - Other for Q1 2023 stood at -$512432.0, down from $512432.0 in the prior quarter.
- Over the last five years, Receivables - Other for RLMD reached as high as $512432.0 in Q4 2022 and fell as low as -$512432.0 in Q1 2023.
- Historically, Receivables - Other has averaged $9254.8 across 4 years, with a median of -$84725.5 in 2019.
- On a YoY basis, Receivables - Other climbed as much as 5177.14% in 2019 and fell as far as 2223.49% in 2019.
- Year by year, Receivables - Other stood at -$176980.0 in 2019, then jumped by 104.25% to $7529.0 in 2020, then jumped by 6706.11% to $512432.0 in 2022, then slumped by 200.0% to -$512432.0 in 2023.
- Per Business Quant data, the three most recent Receivables - Other figures were -$512432.0 in Q1 2023, $512432.0 in Q4 2022, and $7529.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Relmada Therapeutics | 205.29 Mn | 205.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -512,432.00 |
| Mar 31, 2023 | -512,432.00 |
| Dec 31, 2022 | 512,432.00 |
| Dec 31, 2022 | 512,432.00 |
| Mar 31, 2020 | 7,529.00 |
| Mar 31, 2020 | 7,529.00 |
| Dec 31, 2019 | -176,980.00 |
| Dec 31, 2019 | -176,980.00 |
| Sep 30, 2019 | -176,980.00 |
| Sep 30, 2019 | -176,980.00 |
| Jun 30, 2019 | 401,960.00 |
| Jun 30, 2019 | 401,960.00 |
| Sep 30, 2018 | -7,617.00 |
| Sep 30, 2018 | -7,617.00 |
| Jun 30, 2018 | 7,617.00 |
| Jun 30, 2018 | 7,617.00 |
| Dec 31, 2017 | -150,617.00 |
| Dec 31, 2017 | -150,617.00 |
| Sep 30, 2017 | 150,617.00 |
| Sep 30, 2017 | 150,617.00 |